Columnist Oluwatosin Adesoye addresses some of the myths about blood transfusion and explains why it's important in managing ...

Digital cognitive behavioral therapy was as effective as pain education at easing sickle cell pain, a study reported.

Cyclosporin H boosts a new lentivirus-delivered gene therapy with enhanced anti-sickling properties in blood stem cells from ...

Clinton Health Access Initiative will use award to expand access to SCD diagnostic tests and treatment in low- and ...

Too many people with sickle cell disease are dying preventable deaths. This negligence must end, columnist Mary Shaniqua says ...

Wilson celebrates the first U.S. patient to complete gene therapy for sickle cell, but says advocacy must continue.

It may be possible to collect nearly three times as many stem cells for sickle cell gene therapy with motixafortide than standard plerixafor.

The U.S. Food and Drug Administration (FDA) gave the greenlight for Iomab-ACT, a potentially less toxic conditioning regimen, to be tested in people with sickle cell disease (SCD) undergoing a stem ...